Cellsight Technologies, Inc.
San Francisco, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 185 Berry St #350, San Francisco, CA 94107, USA
- Website
- cellsighttech.com
- Founded
- 2009
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Regents Of The University Of California. San Francisco | R01HL160688 | $1,145,828 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Theracea Pharma LC | Tucson, AZ | — |
| Collagen Medical LLC | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Chesapeake Medical Imaging | — | 621512 Diagnostic Imaging Centers |
| Trevarx Biomedical, Inc. | Philadelphia, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Quantitative Imaging Systems LLC | Pittsburgh, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Cellsight Technologies, Inc. is a molecular imaging company based in San Francisco, California, registered as a woman-owned small business in the System for Award Management (SAM) since 2009. The company specializes in developing advanced PET imaging agents and provides technical support and research services primarily focused on medical imaging technologies for cancer and neurodegenerative disease applications. As a for-profit organization, Cellsight Technologies leverages its expertise in molecular imaging to support federal research initiatives through contract and grant awards.
Through its federal contract awards, Cellsight Technologies has been awarded a Small Business Innovation Research (SBIR) Phase II contract from the National Cancer Institute (NCI) valued at $1,995,174. The contract focuses on developing the [18F]F-ARAG imaging agent to quantitatively assess response to immunotherapy in non-small cell lung cancer. The contract is set aside for small businesses and is structured as a definitive contract with a completion date of September 15, 2026. This award builds upon a previous $300,000 SBIR Phase I contract and demonstrates the company's capability to advance innovative medical imaging technologies for cancer research.
In terms of federal grant awards, Cellsight Technologies has received a substantial Project Grant from the National Institute on Aging totaling $871,261, aimed at investigating the use of the PET imaging agent [18F]F-ARAG as a biomarker for detecting T cell activity in Alzheimer's disease patients. Additionally, the company has been involved in multiple sub-grant awards, including collaborative projects with the University of California, San Francisco, focused on imaging cardiac toxicity associated with cancer therapies. These sub-awards involve providing technical support, precursor materials, and expertise in analyzing and interpreting research results related to [18F]F-ARAG's applications in monitoring immune responses and potential cardiotoxicity in cancer treatments.
Quick answers
Is Cellsight Technologies, Inc. registered in SAM.gov?
Yes. Cellsight Technologies, Inc.'s SAM.gov registration is active through August 25, 2027.
What is Cellsight Technologies, Inc.'s CAGE code?
Cellsight Technologies, Inc.'s CAGE code is 5T0V1, and its Unique Entity ID (UEI) is E3UQXACGFR43.
What is Cellsight Technologies, Inc.'s most recent federal award?
Cellsight Technologies, Inc.'s most recent federal grant award is Imaging intracerebral and systemic T cell immunity in patients with alzheimer's disease using 18F-F-arag (R44AG094397), from National Institute on Aging (NIH), on September 20, 2025.
On GovTribe
See Cellsight Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors